Ticker

Shares in Oxford Nanopore Technologies PLC (LSE:ONT) fell 16% to 101.2 pence after the company said first-half trading had come in below management expectations. The maker of nanopore-based technology for analysing DNA and RNA, expects revenue of around £116.5 million for the six months to 30 June.

Oxford Nanopore Technologies PLC (LSE:ONT), the LSE-listed DNA sequencing company, has drawn positive reviews from RBC Capital Markets and Citi following its annual London Calling customer conference last week, with both brokers reiterating buy-equivalent ratings on the stock. RBC Capital Markets carries an outperform rating and 225p target price, while Citi rates the shares buy with a high-risk designation, noting…